Description:
Anti-Complement C5 Reference Antibody (ravulizumab)(CHA747) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
Product type:
Antibody
Host:
CHO
Target name:
Complement C5
Target species:
Human
Isotype:
IgG
Buffer:
100 mM Pro-Ac 20 mM Arg pH5.0
Applications:
ELISA、FACS、Kinetics (BLI)、Kinetics (SPR)、Functional assay
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com